Target intelligence / Profile preview

Bicaudal C homolog 1 (BICC1)

Target
BICC1
Molecular classification
RNA-binding protein, Post-transcriptional regulator, Other
01

Overview

Bicaudal C homolog 1 (BICC1) is an evolutionarily conserved, multi-domain RNA-binding protein that regulates gene expression at the post-transcriptional level. It contains several K-homology (KH) domains in its N-terminal region which confer specificity for target mRNA binding, and it can interact with the Ccr4-Not deadenylase complex to modulate mRNA stability and translation. BICC1 is important for embryonic development—especially in left-right patterning in vertebrates—by regulating the translation or decay of specific mRNAs such as **dand5, gdf3**, and **PkD2**. It can repress or, in some cases, activate specific mRNA targets, often interacting with microRNAs and their associated proteins (e.g., AGO2, Dicer) to fine-tune post-transcriptional regulation. Mutations or loss of BICC1 cause cystic kidney and liver diseases in mice and are implicated in human polycystic kidney disease. Rare fusions such as FGFR2-BICC1 occur in certain tumor types and may represent oncogenic drivers[1][2][3][4].

Other names
Protein bicaudal C homolog 1BicCBICCFGFR2-BICC1 fusion kinase proteinbicc1
02

Mechanism of action

Not applicable; no known drugs directly target BICC1

03

Biological functions

Regulation of mRNA translationmRNA stabilityEmbryonic developmentLeft-right patterningPost-transcriptional gene regulation
04

Disease associations

Polycystic kidney diseaseDevelopmental disordersCancer (via FGFR2-BICC1 fusion in some tumors)Other
05

Safety considerations

Not a direct therapeutic target, so not applicable; loss of function is associated with cystic kidney diseases[2][3]
06

Biomarkers

No routine clinical biomarkers, but loss-of-function or fusion status is associated with some developmental diseases and cancers[2][3]

Beyond the preview

Go deeper on Bicaudal C homolog 1 (BICC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bicaudal C homolog 1 (BICC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call